blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2531191

EP2531191 - Sigma ligands for use in the prevention and/or treatment of postoperative pain [Right-click to bookmark this link]
Former [2012/50]SIGMA LIGANDS FOR USE IN THE PREVENTION AND/OR TREATMENT OF POSTOPERATIVE PAIN
[2015/42]
StatusNo opposition filed within time limit
Status updated on  03.02.2017
Database last updated on 15.06.2024
Most recent event   Tooltip03.02.2017No opposition filed within time limitpublished on 08.03.2017  [2017/10]
Applicant(s)For all designated states
Laboratorios del Dr. Esteve, S.A.
Avda Mare de Deu de Montserrat 221
08041 Barcelona / ES
[2016/13]
Former [2012/50]For all designated states
Laboratorios del. Dr. Esteve, S.A.
Avda Mare de Deu de Montserrat 221
08041 Barcelona / ES
Inventor(s)01 / VELA HERNÁNDEZ, José Miguel
Avda. Badal nº 153, 8º, 3ª
E- 08028 Barcelona / ES
02 / ZAMANILLO- CASTANEDO, Daniel
Avda. Mare de Dèu de Montserrat
252, 5º- 2ª
E-08041 Barcelona / ES
03 / PUIG-RIERA de CONIAS, Margarita
c/Roger de Lluria 8 3°1
E-08010 Barcelona / ES
 [2012/50]
Representative(s)ABG Intellectual Property Law, S.L.
Avenida de Burgos, 16D
Edificio Euromor
28036 Madrid / ES
[N/P]
Former [2012/50]ABG Patentes, S.L.
Avenida de Burgos, 16D
Edificio Euromor
28036 Madrid / ES
Application number, filing date11702057.804.02.2011
[2016/13]
WO2011EP51643
Priority number, dateEP2010038202404.02.2010         Original published format: EP 10382024
[2012/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011095584
Date:11.08.2011
Language:EN
[2011/32]
Type: A1 Application with search report 
No.:EP2531191
Date:12.12.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 11.08.2011 takes the place of the publication of the European patent application.
[2012/50]
Type: B1 Patent specification 
No.:EP2531191
Date:30.03.2016
Language:EN
[2016/13]
Search report(s)International search report - published on:EP11.08.2011
ClassificationIPC:A61K31/415, A61K31/416, A61K31/4196, A61P29/00
[2012/50]
CPC:
A61K31/00 (EP,US); A61K31/415 (EP,CN,KR,US); A61K31/5377 (EP,CN,US);
A61K31/4025 (CN); A61K31/416 (EP,KR,US); A61K31/4178 (CN);
A61K31/4196 (EP,CN,KR,US); A61K31/4439 (CN); A61K31/454 (CN);
A61K31/4725 (CN); A61K31/496 (CN); A61K31/55 (CN);
A61P25/00 (EP); A61P25/04 (EP); A61P29/00 (EP);
A61P43/00 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/50]
Extension statesBA30.08.2012
ME30.08.2012
TitleGerman:Sigma-Liganden zur Anwendung in der Vorbeugung und/oder Behandlung von postoperativem Schmerz[2015/42]
English:Sigma ligands for use in the prevention and/or treatment of postoperative pain[2015/42]
French:Ligands sigma pour utilisation dans la prévention et/ou le traitement de la douleur post-opératoire[2015/42]
Former [2012/50]SIGMA-LIGANDEN ZUR VORBEUGUNG UND/ODER BEHANDLUNG VON POSTOPERATIVEM SCHMERZ
Former [2012/50]SIGMA LIGANDS FOR USE IN THE PREVENTION AND/OR TREATMENT OF POSTOPERATIVE PAIN
Former [2012/50]LIGANDS SIGMA DESTINÉS À ÊTRE UTILISÉS POUR LA PRÉVENTION ET/OU LE TRAITEMENT DE LA DOULEUR POSTOPÉRATOIRE
Entry into regional phase30.08.2012National basic fee paid 
30.08.2012Designation fee(s) paid 
30.08.2012Examination fee paid 
Examination procedure30.08.2012Amendment by applicant (claims and/or description)
30.08.2012Examination requested  [2012/50]
03.12.2013Despatch of a communication from the examining division (Time limit: M04)
01.04.2014Reply to a communication from the examining division
13.04.2015Despatch of a communication from the examining division (Time limit: M04)
27.07.2015Reply to a communication from the examining division
28.09.2015Communication of intention to grant the patent
27.01.2016Fee for grant paid
27.01.2016Fee for publishing/printing paid
27.01.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  03.12.2013
Opposition(s)03.01.2017No opposition filed within time limit [2017/10]
Fees paidRenewal fee
08.02.2013Renewal fee patent year 03
21.01.2014Renewal fee patent year 04
16.01.2015Renewal fee patent year 05
11.01.2016Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO2006021462  (ESTEVE LABOR DR [ES], et al) [X] 1-10,16,17* claims 1,15 *;
 [Y]EP1787679  (ESTEVE LABOR DR [ES]) [Y] 1-10,16,17 * claims 1,12-24 *;
 [Y]WO2008015266  (ESTEVE LABOR DR [ES], et al) [Y] 1-10,16,17 * claims 1,32 *;
 [Y]WO2009103487  (ESTEVE LABOR DR [ES], et al) [Y] 1-10,16,17 * claims 1,5 *
by applicantWO2006021462
 WO2006021463
 WO2008055932
    - T.J. BRENNAN ET AL., PAIN, (1996), vol. 64, pages 493 - 501
    - P.K. ZAHN ET AL., REGIONAL ANESTHESIA AND PAIN MEDICINE 2002, (200209), vol. 27, no. 5, pages 514 - 516
    - G. RONSISVALLE ET AL., PURE APPL. CHEM., (2001), vol. 73, pages 1499 - 1509
    - R. QUIRON ET AL., TRENDS PHARMACOL. SCI., (1992), vol. 13, pages 85 - 86
    - M.L.LEITNER, EUR. J. PHARMACOL., (1994), vol. 259, pages 65 - 69
    - S.B. HELLEWELL; W.D. BOWEN, BRAIN RES., (1990), vol. 527, pages 244 - 253
    - PRASAD, P.D. ET AL., J. NEUROCHEM., (1998), vol. 70, no. 2, pages 443 - 451
    - "pain initiated or caused by a primary lesion or dysfunction in the nervous system", IASP, Classification of chronic pain, IASP PRESS, (2002), page 210
    - IASP, Classification of chronic pain, IASP PRESS, (2002), page 210
    - IASP, Classification of chronic pain, IASP PRESS, (2002), page 213
    - IASP, Classification of chronic pain, IASP PRESS, (2002), page 211
    - IASP, Classification of chronic pain, IASP PRESS, (2002), page 212
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.